1. Home
  2. UFI vs ATYR Comparison

UFI vs ATYR Comparison

Compare UFI & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unifi Inc. New

UFI

Unifi Inc. New

N/A

Current Price

$3.65

Market Cap

74.1M

ML Signal

N/A

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

N/A

Current Price

$0.80

Market Cap

83.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UFI
ATYR
Founded
1969
2005
Country
United States
United States
Employees
N/A
59
Industry
Textiles
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
83.3M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
UFI
ATYR
Price
$3.65
$0.80
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
$4.20
AVG Volume (30 Days)
33.4K
1.1M
Earning Date
04-29-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
57.47
N/A
EPS
N/A
N/A
Revenue
$571,344,000.00
N/A
Revenue This Year
$1.39
N/A
Revenue Next Year
$12.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.96
$0.64
52 Week High
$5.68
$7.29

Technical Indicators

Market Signals
Indicator
UFI
ATYR
Relative Strength Index (RSI) 47.14 41.17
Support Level $3.73 $0.67
Resistance Level $4.77 $0.85
Average True Range (ATR) 0.14 0.06
MACD -0.01 -0.02
Stochastic Oscillator 51.02 5.06

Price Performance

Historical Comparison
UFI
ATYR

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: